Literature DB >> 25673774

Role of domain calcium in purinergic P2X2 receptor channel desensitization.

Claudio Coddou1, Zonghe Yan2, Stanko S Stojilkovic2.   

Abstract

Activation of P2X2 receptor channels (P2X2Rs) is characterized by a rapid current growth accompanied by a decay of current during sustained ATP application, a phenomenon known as receptor desensitization. Using rat, mouse, and human receptors, we show here that two processes contribute to receptor desensitization: bath calcium-independent desensitization and calcium-dependent desensitization. Calcium-independent desensitization is minor and comparable during repetitive agonist application in cells expressing the full size of the receptor but is pronounced in cells expressing shorter versions of receptors, indicating a role of the COOH terminus in control of receptor desensitization. Calcium-dependent desensitization is substantial during initial agonist application and progressively increases during repetitive agonist application in bath ATP and calcium concentration-dependent manners. Experiments with substitution of bath Na(+) with N-methyl-d-glucamine (NMDG(+)), a large organic cation, indicate that receptor pore dilation is a calcium-independent process in contrast to receptor desensitization. A decrease in the driving force for calcium by changing the holding potential from -60 to +120 mV further indicates that calcium influx through the channel pores at least partially accounts for receptor desensitization. Experiments with various receptor chimeras also indicate that the transmembrane and/or intracellular domains of P2X2R are required for development of calcium-dependent desensitization and that a decrease in the amplitude of current slows receptor desensitization. Simultaneous calcium and current recording shows development of calcium-dependent desensitization without an increase in global intracellular calcium concentrations. Combined with experiments with clamping intrapipette concentrations of calcium at various levels, these experiments indicate that domain calcium is sufficient to establish calcium-dependent receptor desensitization in experiments with whole-cell recordings.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  ATP; calcium; desensitization; pore dilation; purinergic receptors

Mesh:

Substances:

Year:  2015        PMID: 25673774      PMCID: PMC4420791          DOI: 10.1152/ajpcell.00399.2014

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  41 in total

1.  Localization and functional expression of splice variants of the P2X2 receptor.

Authors:  J Simon; E J Kidd; F M Smith; I P Chessell; R Murrell-Lagnado; P P Humphrey; E A Barnard
Journal:  Mol Pharmacol       Date:  1997-08       Impact factor: 4.436

2.  Identification of amino acid residues contributing to desensitization of the P2X2 receptor channel.

Authors:  T Koshimizu; M Tomić; M Koshimizu; S S Stojilkovic
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

3.  Highly conserved tyrosine 37 stabilizes desensitized states and restricts calcium permeability of ATP-gated P2X3 receptor.

Authors:  Marie Jindrichova; Kamil Khafizov; Andrei Skorinkin; Dmitriy Fayuk; Genevieve Bart; Hana Zemkova; Rashid Giniatullin
Journal:  J Neurochem       Date:  2011-10-10       Impact factor: 5.372

4.  A memory for extracellular Ca2+ by speeding recovery of P2X receptors from desensitization.

Authors:  S P Cook; K D Rodland; E W McCleskey
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

Review 5.  Purinergic signalling: from normal behaviour to pathological brain function.

Authors:  Geoffrey Burnstock; Ute Krügel; Maria P Abbracchio; Peter Illes
Journal:  Prog Neurobiol       Date:  2011-09-01       Impact factor: 11.685

6.  A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening.

Authors:  Ralf Hausmann; Gregor Bahrenberg; Daniel Kuhlmann; Michaela Schumacher; Ursula Braam; Dagmar Bieler; Ilka Schlusche; Günther Schmalzing
Journal:  Neuropharmacology       Date:  2014-01-19       Impact factor: 5.250

7.  Functional modulation of P2X2 receptors by cyclic AMP-dependent protein kinase.

Authors:  Y W Chow; H L Wang
Journal:  J Neurochem       Date:  1998-06       Impact factor: 5.372

8.  Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons.

Authors:  C Lewis; S Neidhart; C Holy; R A North; G Buell; A Surprenant
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

9.  Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding.

Authors:  Sébastien Roger; Pablo Pelegrin; Annmarie Surprenant
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

10.  Identification of negative residues in the P2X3 ATP receptor ectodomain as structural determinants for desensitization and the Ca2+-sensing modulatory sites.

Authors:  Elsa Fabbretti; Elena Sokolova; Lara Masten; Marianna D'Arco; Alessandra Fabbro; Andrea Nistri; Rashid Giniatullin
Journal:  J Biol Chem       Date:  2004-10-08       Impact factor: 5.157

View more
  3 in total

Review 1.  Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function.

Authors:  Brian F King
Journal:  Purinergic Signal       Date:  2022-10-24       Impact factor: 3.950

2.  Cyclin-dependent kinase 5 modulates the P2X2a receptor channel gating through phosphorylation of C-terminal threonine 372.

Authors:  Claudio Coddou; Rodrigo Sandoval; Patricio Castro; Pablo Lazcano; Maria José Hevia; Milos Rokic; Bradford Hall; Anita Terse; Christian Gonzalez-Billault; Ashok B Kulkarni; Stanko S Stojilkovic; Elias Utreras
Journal:  Pain       Date:  2017-11       Impact factor: 7.926

3.  Opposing Roles of Calcium and Intracellular ATP on Gating of the Purinergic P2X2 Receptor Channel.

Authors:  Milos B Rokic; Patricio Castro; Elias Leiva-Salcedo; Melanija Tomic; Stanko S Stojilkovic; Claudio Coddou
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.